CVS to Pay $315 Million to Resolve Opioid Prescription Lawsuit
WHO:
ABC News - CVS Pharmacy Inc. and its subsidiaries are involved in the case.
AP News - The Justice Department is the entity bringing the case against CVS.
WHAT:
Fast Company - The lawsuit was filed in 2024, accusing CVS of unlawfully dispensing medically unnecessary prescriptions of highly addictive opioids.
Fast Company - Associate Attorney General Stanley Woodward stated, “Today’s settlement is a significant milestone in the Justice Department’s efforts to combat the opioid epidemic by cracking down on pharmacies who unlawfully fulfill prescriptions for controlled substances.”
Fast Company - The lawsuit alleges that poor staffing levels, performance metrics, and incentive compensation policies led to pharmacists racing to fill prescriptions without confirming their legitimacy.
Fast Company - The prescriptions were often billed to and reimbursed by Medicaid and other federal healthcare programs.
Fast Company - Assistant Attorney General Brett Shumate stated that CVS must implement additional safeguards to ensure that prescriptions for opioids and other controlled substances are dispensed only when medically appropriate.
Fast Company - The lawsuit accused CVS of prescribing massive amounts of opioids and other controlled substances “to fuel its own profits at the expense of public health and safety.”
Fast Company - The lawsuit was filed under President Joe Biden's administration and accused CVS of violating the Controlled Substances Act by filling illegitimate prescriptions for high doses of potent opioids that “fed dependence and addiction.”
Fast Company - The Justice Department alleged that CVS dispensed large quantities of opioids based on prescriptions from known “pill mills.”
Fast Company - Under the settlement, CVS must implement additional safeguards to ensure that prescriptions for opioids and other controlled substances are dispensed only when medically appropriate.
Fast Company - Over the last decade, drugmakers, wholesalers, pharmacies, and other companies have agreed to settlements with governments in the U.S. totaling over $50 billion, with most of the money intended to address the opioid crisis linked to more than 100,000 deaths in the U.S. in some years.
ABC News - CVS has agreed to pay $315 million to resolve allegations of unlawfully dispensing medically unnecessary prescriptions of opioids.
AP News - The settlement amount is $315 million.
WHERE:
ABC News - The case involves CVS Pharmacy, which operates nationwide in the United States.
WHY:
ABC News - The allegations against CVS pertain to the unlawful dispensing of highly addictive opioids.
HOW:
ABC News - The resolution of the case is through a financial settlement.
(UPDATED October 14, 2026 03:02 UTC)
The Justice Department has reached a settlement with CVS over a lawsuit filed in 2024, which accused the pharmacy chain of unlawfully dispensing medically unnecessary prescriptions for highly addictive opioids. Associate Attorney General Stanley Woodward emphasized that this settlement marks a significant milestone in the fight against the opioid epidemic, highlighting the need for pharmacies to adhere to strict guidelines when fulfilling prescriptions. As part of the agreement, CVS will implement additional safeguards to ensure that prescriptions for opioids and other controlled substances are dispensed only when they are medically appropriate.
--
(UPDATED October 13, 2026 20:02 UTC)
CVS is facing a lawsuit that accuses the company of prescribing large amounts of opioids and other controlled substances to boost its profits, compromising public health and safety. The Justice Department claims that CVS filled illegitimate prescriptions from known "pill mills," violating the Controlled Substances Act, and as part of a settlement, the company will need to implement new safeguards to ensure that such prescriptions are only dispensed when medically appropriate. Over the past decade, various entities, including drugmakers and pharmacies, have settled with U.S. governments for over $50 billion to help tackle the opioid crisis, which has been linked to more than 100,000 deaths in certain years.
--
(UPDATED October 13, 2026 19:09 UTC)
CVS Pharmacy Inc. and its subsidiaries have agreed to pay $315 million to resolve allegations brought by the Justice Department regarding the unlawful dispensing of medically unnecessary opioid prescriptions. This settlement addresses serious concerns about CVS's role in the distribution of highly addictive opioids across the United States. The resolution comes in the form of a financial settlement to put these allegations to rest.